The Daily News Now! Business

Got that credit card bill piling up? High interest rates got you stressed? Here’s the good news: 84% of people who asked for a lower rate actually got one—highest success rate in years. Banks still want your business, even with rates at 21%. They’ll negotiate, waive fees, or slash rates to keep you loyal. Only 23% of cardholders even tried—yet 90% who asked for fee waivers got them, and 94% saw an...

Goldman Sachs just flipped its oil forecast—last week predicting a massive surplus, now warning of supply chain chaos as Middle East tensions flare. With production still 10.5 million barrels below pre-war levels and tanker traffic near zero in the Strait of Hormuz, global refilling efforts are stalled. Strategic reserves are low, and with ceasefire talks hanging in the balance, markets brace for...

Cash isn’t everything—how companies spend it matters. While Lockheed Martin piles up cash, its profits are slipping and growth is sluggish. Meanwhile, Arlo Technologies and JBT Marel are turning cash into explosive growth, with soaring revenues and profits. The real winners? Those that invest wisely and capture market share. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com...

Companies with piles of cash might seem like safe bets, but deeper looks reveal troubling signs: slow revenue growth, stagnant profits, and missed opportunities. DoubleVerify, despite cutting-edge AI ad verification tech, struggles with sluggish sales returns and weak margins. FB Financial, a century-old bank, lags behind peers in revenue and profit growth. Cathay General Bancorp, strong in Asian-...

SpaceX’s record-breaking $75 billion IPO sent its market value soaring to $1.7 trillion—but history warns that mega-IPOs often slump in their first year. With less than 5% of shares currently tradable and insiders still locked in, a flood of new supply could crush the price. Trading at an extreme valuation, SpaceX may be overhyped right now. Consider other growth plays before diving in. Listen in...

Value stocks may look cheap on paper, but are they truly undervalued—or just value traps? Wix, Paramount, and United Airlines show why: slowing growth, rising costs, and shrinking cash flow. Meanwhile, explosive growth stocks are delivering hundreds of percent returns. The key? Don’t chase low prices blindly—find the rare combo of a strong business and a fair price. Listen in comfort: Get a discou...

For centuries, kids were economic assets— hauling water, tending fields, even mining— but today, childhood is seen as a sacred, protected phase. Historians trace this shift to the 19th century, with Philippe Ariès arguing that our modern view of children as individuals, not laborers, is a relatively new invention. Now, as birthrates drop in wealthy nations, society’s focus on children’s well-being...

Value stocks aren’t just about low prices—they’re about finding gems hidden beneath the surface. Asana looks like a potential trap with slowing growth and complex sales cycles, while Morningstar shines with strong sales, smart buybacks, and stellar returns. EQT, the top U.S. natural gas producer, is a cash-flow powerhouse with solid fundamentals. The key? Spotting the real bargains before they’re...

Kalshi is poised to revolutionize trading by launching never-expiring derivative products for metals, FX, and energy — a bold move to challenge Wall Street giants. With CFTC approval for crypto perpetuals already in hand, they’re now seeking the same green light for gold and other assets, tapping into both retail and institutional demand. But these high-leverage, infinite-duration contracts come w...

Tesla’s robotaxi ambitions are running behind schedule, delaying investor confidence and dragging down stock performance, but the company’s core car sales are holding strong — a crucial lifeline as it braces for a $25 billion capital spending year, with the v15 full-self-driving software and its impact on robotaxi timelines set to dominate the next earnings call. Listen in comfort: Get a discount...

AI stocks are booming—but volatility is on the horizon. For investors seeking stability, the Vanguard Value ETF (VTV) offers a steady alternative. With just 13% in tech and heavy exposure to blue-chip giants like JPMorgan and Berkshire Hathaway, VTV delivers consistent dividends and resilience during downturns. Since 2004, it’s returned 9.6% annually—slightly less than the S&P 500, but with nearly...

The Fed just got a new chair, Kevin Warsh, who’s ready to overhaul the central bank—starting with ditching forward-looking guidance and letting markets react to real data. With inflation hitting a three-year high and core prices stubbornly rising, Warsh’s hawkish stance signals imminent rate hikes. As oil prices cool but inflation spreads beyond energy, investors brace for a data-driven, high-stak...

Three industry titans—Lam Research, Caterpillar, and Dell—are rewriting the rules with jaw-dropping growth and razor-sharp margins, but can they keep scaling without overextending? Lam Research rockets ahead with 23% annual revenue gains and stellar cash conversion, Caterpillar turns heavy machinery into cash flow gold with strong parts revenue, and Dell, born in a dorm room, now fuels global IT w...

Mid-cap stocks are the hidden gems of the market—proven, scalable, and often overlooked. But not all are created equal. Semtech’s efficiency is tanking, margins are collapsing, and returns on capital are falling—big red flags. Generac’s generator business is slowing, earnings are slipping, and capital returns are fading—classic signs of stagnation. But flip the script: Nextpower is soaring, revenu...

Biotech showdown: Axsome Therapeutics and Revolution Medicines are both hot picks, but which one’s the smarter bet? Axsome’s already got three approved drugs driving revenue—with recent approvals for Alzheimer’s and migraines fueling 59% and 34% sales jumps—and a strong late-stage pipeline. Revolution’s still early, no drugs on the market yet, but its groundbreaking tech is showing massive surviva...

Growth stocks may be cooling—here’s why investors are digging deeper to find true long-term winners. Teradyne’s semiconductor testing gear saw a 30% revenue spike, but its five-year growth is just 3.5% and cash flow margins are collapsing. First Watch’s brunch spots are losing same-store sales and carry heavy debt, making future funding risky. Black Stone Minerals’ oil and gas rights are shrinking...

Delta’s latest quarter smashed records with $14.2 billion in revenue, up nearly 10% year-over-year, and strong profits helped shrink debt—making their finances healthier than pre-pandemic. CEO’s bullish on next quarter’s billion-dollar profit forecast despite rising fuel costs, thanks to cash-generating perks like credit cards and premium seats. But is it time to buy? Investors see potential value...

The stock market’s soaring on AI hype, with Nasdaq and S&P 500 hitting record highs and the Dow breaking 53K — but Warren Buffett’s warning lights are flashing. His Buffett Indicator, now at a record 235%, signals extreme valuation, echoing past crashes after similar readings. History shows markets tumble when this metric climbs above 200% — so while it’s not time to panic sell, it’s a wake-up cal...

Private credit, Europe’s shadow banking powerhouse now worth $3.1 trillion, is under intense scrutiny as regulators race to understand its risks. Born from banks’ post-2008 retreat, this high-growth sector funds everything from private equity to riskier ventures—but at what cost? With weak transparency and loose oversight, it could trigger wider financial shocks. The European Systemic Risk Board i...

South Korea’s Kospi just crashed into bear territory after a meteoric rise, shedding 20% from its June peak — a wild swing fueled by AI hype and extreme concentration in giants like Samsung and SK Hynix. Global skepticism about AI’s growth pace, plus heavy bets on these two stocks, triggered a mass exit. But don’t panic: fundamentals remain strong with rising memory prices and looming shortages. T...

A thousand bucks in Tesla a decade ago? Now worth over $27K. That’s the kind of explosive growth investors are now eyeing for SpaceX—especially with Elon Musk at the wheel. But while SpaceX’s ambitions stretch from Starlink and AI to space data centers and Mars colonization, replicating Tesla’s 6,000% first-decade surge (averaging nearly 40% annually) is a tall order. Big IPOs often take time to m...

US military strikes hit Iran’s air defenses and missile sites, escalating tensions after Iran retaliated against American allies in the Gulf. With President Trump vowing a 20-to-1 retaliation for every Iranian strike, the region braces for further conflict as the Strait of Hormuz faces severe disruption and global oil markets react. Iran warns of consequences for US aggression, while key peace tal...

Building wealth over the long haul isn’t about complex tricks—it’s about investing in companies that grow sales, boost profits, and maximize returns on capital. Three standout picks deliver legendary returns: Alphabet (Google’s parent), with 180% growth thanks to search, cloud, and YouTube; Cencora, a pharmaceutical giant with 160% growth via scale and buybacks; and American Express, up 96% with s...

Delaying Social Security past your full retirement age could add over $182,000 to your lifetime income—yet many miss this chance. While you can start at 62, waiting until 70 boosts monthly checks dramatically. But it’s not universal: health, finances, and personal goals matter. For some, claiming early makes sense; for others, patience pays off big. Listen in comfort: Get a discount on a Soli Pill...

Hot stocks are tempting, but beware: recent momentum doesn’t guarantee long-term success. While Callaway Golf and HNI show short-term gains, they’re struggling with slow revenue, weak cash flow, and heavy debt. In contrast, Vertex Pharmaceuticals stands out with strong sales growth, healthy cash flow, and a track record of profitable innovation—making it a smarter play for investors looking beyond...